FR2516922B1 - - Google Patents

Info

Publication number
FR2516922B1
FR2516922B1 FR8122020A FR8122020A FR2516922B1 FR 2516922 B1 FR2516922 B1 FR 2516922B1 FR 8122020 A FR8122020 A FR 8122020A FR 8122020 A FR8122020 A FR 8122020A FR 2516922 B1 FR2516922 B1 FR 2516922B1
Authority
FR
France
Prior art keywords
radical
hydrogen
lower alkyl
derivatives
phenyl radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8122020A
Other languages
English (en)
French (fr)
Other versions
FR2516922A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sante SAS
Original Assignee
LIPHA SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIPHA SAS filed Critical LIPHA SAS
Priority to FR8122020A priority Critical patent/FR2516922A1/fr
Priority to ZA828436A priority patent/ZA828436B/xx
Priority to IL67291A priority patent/IL67291A0/xx
Priority to IE2752/82A priority patent/IE54130B1/en
Priority to IN848/DEL/82A priority patent/IN158843B/en
Priority to AU90730/82A priority patent/AU563190B2/en
Priority to HU823764A priority patent/HU192112B/hu
Priority to EP82402137A priority patent/EP0080934B1/fr
Priority to MX888182A priority patent/MX155838A/es
Priority to DE8282402137T priority patent/DE3277970D1/de
Priority to FR8219640A priority patent/FR2536397A2/fr
Priority to CS828426A priority patent/CS248035B2/cs
Priority to NZ202596A priority patent/NZ202596A/en
Priority to MA19863A priority patent/MA19650A1/fr
Priority to SU823516803A priority patent/SU1250171A3/ru
Priority to ES517637A priority patent/ES8308323A1/es
Priority to MX010425A priority patent/MX173498B/es
Priority to DK523082A priority patent/DK164163C/da
Priority to NO823940A priority patent/NO159169C/no
Priority to AT82402137T priority patent/ATE31927T1/de
Priority to OA57850A priority patent/OA07257A/xx
Priority to CA000416354A priority patent/CA1213595A/fr
Priority to DD82245217A priority patent/DD204919A5/de
Priority to JP57205582A priority patent/JPS5896082A/ja
Priority to YU2649/82A priority patent/YU43726B/xx
Publication of FR2516922A1 publication Critical patent/FR2516922A1/fr
Application granted granted Critical
Publication of FR2516922B1 publication Critical patent/FR2516922B1/fr
Priority to YU1630/84A priority patent/YU43675B/xx
Priority to US06/669,037 priority patent/US4602034A/en
Priority to US06/872,381 priority patent/US4783533A/en
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR8122020A 1981-11-25 1981-11-25 Acides (oxo-4-4h-(1)-benzopyran-8-yl) alcanoiques, sels et derives, preparation et medicament les contenant Granted FR2516922A1 (fr)

Priority Applications (28)

Application Number Priority Date Filing Date Title
FR8122020A FR2516922A1 (fr) 1981-11-25 1981-11-25 Acides (oxo-4-4h-(1)-benzopyran-8-yl) alcanoiques, sels et derives, preparation et medicament les contenant
ZA828436A ZA828436B (en) 1981-11-25 1982-11-16 (oxo-4-4h-(1)-benzopyran-8-yl)alcanoic acids, salts and derivatives,their manufacture and medicines containing them
IL67291A IL67291A0 (en) 1981-11-25 1982-11-17 (4-oxo-4h-(1)-benzopyran-8-yl)alkanoic acids and salts and derivatives thereof,their manufacture and pharmaceutical compositions containing them
IE2752/82A IE54130B1 (en) 1981-11-25 1982-11-18 (4-oxo-4h-(1)-benzopyran-8-yl)-alkanoic acids, salts and derivatives, their manufacture and medicines containing them
IN848/DEL/82A IN158843B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1981-11-25 1982-11-18
AU90730/82A AU563190B2 (en) 1981-11-25 1982-11-19 8-carboxyalkyl-4h-benzo(b)pyran-4-ones
HU823764A HU192112B (en) 1981-11-25 1982-11-23 Process for preparing new 4-oxo-4h-/1/-benzo-pyran-8-yl-alkanecarboxylic acids
ES517637A ES8308323A1 (es) 1981-11-25 1982-11-24 Un procedimiento de preparacion de los acidos(oxo-4-4h-(1)-benzopiran-8-il)-alcanoicos.
DE8282402137T DE3277970D1 (en) 1981-11-25 1982-11-24 (4-oxo-4h-(1)-benzopyran-8-yl)-alkanoic acids, salts and derivatives, preparation and medicines containing them
FR8219640A FR2536397A2 (en) 1981-11-25 1982-11-24 [4-oxo-4H-1-Benzopyran-8-yl]alkanoic acids, their salts and derivatives, their preparation and medicinal products containing them
CS828426A CS248035B2 (en) 1981-11-25 1982-11-24 Production method of the(4(oxo-4h)1(-benzopyran-8-yl)carboxyle acides
NZ202596A NZ202596A (en) 1981-11-25 1982-11-24 4-oxo-4h(1)-benzopyran-8-yl-alkanoic acids,derivatives and pharmaceutical compositions
MA19863A MA19650A1 (fr) 1981-11-25 1982-11-24 Procede de preparation d'acide (oxo-4-4H-(1)-benzopuran-8-yl)
SU823516803A SU1250171A3 (ru) 1981-11-25 1982-11-24 Способ получени производных @ 4-(4н)-оксо-8-бензопиранил @ -уксусной кислоты
EP82402137A EP0080934B1 (fr) 1981-11-25 1982-11-24 Acides (oxo-4-4H-(1)-benzopyran-8-yl) alcanoiques, sels et dérivés, préparation et médicaments les contenant
MX010425A MX173498B (es) 1981-11-25 1982-11-24 Procedimiento para la preparacion de acidos 4£- oxo-4h (1)-benzopiran-8-il| alcanoicos y derivados.
DK523082A DK164163C (da) 1981-11-25 1982-11-24 Analogifremgangsmaade til fremstilling af 4-oxo-4h-oe1aa-benzopyran-8-yl-alkansyrer eller estere eller dialkylaminoalkylamider deraf eller alkalimetalsalte deraf samt 4-oxo-4h-oe1aa-benzopyran-8-yl-alkannitriler til anvendelse som mellemprodukter
NO823940A NO159169C (no) 1981-11-25 1982-11-24 Analogifremgansmaate for fremstilling av derivater av (okso-4-4h-(1)-benzopyran-8-yl)eddiksyre med antitumoral terapeutisk aktivitet.
AT82402137T ATE31927T1 (de) 1981-11-25 1982-11-24 (4-oxo-4h-(1)-benzopyran-8-yl)-alkansaueren, salze und derivate, herstellung und diese enthaltende arzneimittel.
MX888182A MX155838A (es) 1981-11-25 1982-11-24 Procedimiento para la preparacion de acidos(4-oxo-4h(1)-benzopiran-bil)alcandicos y derivados de los mismos
OA57850A OA07257A (fr) 1981-11-25 1982-11-25 Acides (oxo-4-4h-(1)-benzopyran-8-yl) alcanoïque, sels et dérivés, préparation et médicaments les contenant.
CA000416354A CA1213595A (fr) 1981-11-25 1982-11-25 Acides ¬oxo-4-4h-(|-benzopyran-8-yl| alcanoique sels et derives, preparation
DD82245217A DD204919A5 (de) 1981-11-25 1982-11-25 Verfahren zur herstellung von (4-oxo-4h-1-benzopyran-8-yl)-alkancarbonsaeuren und deren alkalimetallsalzen, estern, aminoestern und amiden
JP57205582A JPS5896082A (ja) 1981-11-25 1982-11-25 〔４−オキソ−４ｈ−〔１〕−ベンゾピラン−８−イル〕アルカン酸およびその誘導体、その製造方法、およびこれを含有する医薬組成物
YU2649/82A YU43726B (en) 1981-11-25 1982-11-25 Process for obtaining (oxo-4-4h(1)benzopyrane-8-yl-alkanic acids
YU1630/84A YU43675B (en) 1981-11-25 1984-09-21 Process for obtaining derivatives of (oxo-4-4h(1)benzopyrane-8-yl)alcanic acids
US06/669,037 US4602034A (en) 1981-11-25 1984-11-06 (Oxo-4-4H-(1)-benzopyran-8-yl) alkanoic acids, salts and derivatives, their manufacture and medicines containing them
US06/872,381 US4783533A (en) 1981-11-25 1986-05-29 [Oxo-4-4H-[1]-benzopyran-8-yl]alcanoic acids, salts and derivatives, their manufacture and medicines containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8122020A FR2516922A1 (fr) 1981-11-25 1981-11-25 Acides (oxo-4-4h-(1)-benzopyran-8-yl) alcanoiques, sels et derives, preparation et medicament les contenant

Publications (2)

Publication Number Publication Date
FR2516922A1 FR2516922A1 (fr) 1983-05-27
FR2516922B1 true FR2516922B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-02-10

Family

ID=9264332

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8122020A Granted FR2516922A1 (fr) 1981-11-25 1981-11-25 Acides (oxo-4-4h-(1)-benzopyran-8-yl) alcanoiques, sels et derives, preparation et medicament les contenant

Country Status (24)

Country Link
US (2) US4602034A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0080934B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5896082A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE31927T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU563190B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1213595A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS248035B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD204919A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3277970D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK164163C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8308323A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2516922A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU192112B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE54130B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL67291A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN158843B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MA (1) MA19650A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX173498B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO159169C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ202596A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
OA (1) OA07257A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU1250171A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (2) YU43726B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA828436B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2536397A2 (en) * 1981-11-25 1984-05-25 Lipha [4-oxo-4H-1-Benzopyran-8-yl]alkanoic acids, their salts and derivatives, their preparation and medicinal products containing them
DE3311004A1 (de) * 1983-03-25 1984-09-27 Bayer Ag, 5090 Leverkusen Chromon- und thiochromon-8-aldehyde, sowie ein verfahren zu ihrer herstellung
JPS62215581A (ja) * 1986-03-18 1987-09-22 Koichi Shiyudo フラボンカルボン酸誘導体
IL85554A0 (en) * 1987-03-02 1988-08-31 Takeda Chemical Industries Ltd Chromone derivatives
USH1427H (en) * 1988-04-06 1995-04-04 Briet; Phillipe Substituted flavonoid compounds, their salts, their manufacture and their use in combination with interleukin-2
IL89840A (en) * 1988-04-06 1996-10-31 Lipha Substituted flavonoid compounds and salts thereof their preparation and pharmaceutical composition containing them
US5116954A (en) * 1988-04-06 1992-05-26 Lipha, Lyonnaise Industrielle Pharmaceutique Pharmaceutically useful flavonoic compounds containing at least one substituent on the benzopyranone ring moiety
US5126129A (en) * 1988-05-23 1992-06-30 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Cancer therapy using interleukin-2 and flavone compounds
US5238954A (en) * 1989-01-19 1993-08-24 The Upjohn Company Fluorinated flavone acetic acid
DE68913997T2 (de) * 1989-01-19 1994-07-28 Upjohn Co Fluorierte flavon-essigsäure.
SK281016B6 (sk) * 1992-02-05 2000-10-09 Boehringer Ingelheim Kg Amidínové deriváty, spôsob ich výroby, použitie a farmaceutické prostriedky s ich obsahom
US5703130A (en) * 1995-06-07 1997-12-30 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Chalcone retinoids and methods of use of same
US5716982A (en) * 1995-06-07 1998-02-10 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Retinoids and methods of use of same
US5968940A (en) * 1995-06-08 1999-10-19 Institute Of Materia Medica Retinoids and methods of use of same
JP4638098B2 (ja) * 1999-06-14 2011-02-23 キャンサー・リサーチ・テクノロジー・リミテッド 癌治療
CA2389924A1 (en) 2000-01-24 2001-07-26 Jozef S. Mruk Use of flavone 8-acetic acid in vascular and cardiovascular interventions and acute coronary syndromes
AU2001282717A1 (en) * 2000-07-28 2002-02-13 Cancer Research Technology Limited Cancer treatment by combination therapy
GB0121285D0 (en) * 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) * 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) * 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
GB0321999D0 (en) * 2003-09-19 2003-10-22 Cancer Rec Tech Ltd Anti-cancer combinations
JP2009506019A (ja) * 2005-08-26 2009-02-12 アンティソーマ・ピーエルシー 癌治療のための組み合わせ
WO2011023287A1 (en) 2009-08-27 2011-03-03 Merck Patent Gmbh Use of faa and its derivatives in cosmetics and dermatology
DK2496567T3 (en) 2009-11-05 2017-10-30 Rhizen Pharmaceuticals S A PRESENT UNKNOWN BENZOPYRANKINA MODULATORS
CN103304531A (zh) * 2013-06-25 2013-09-18 南方医科大学 一种3-芳基黄酮乙酸
WO2017156520A1 (en) * 2016-03-11 2017-09-14 H. Lee Moffitt Cancer Center And Research Institute, Inc. Icariin and icaritin derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921070A (en) * 1957-11-05 1960-01-12 Recordati Lab Farmacologico S Basic esters of 3-methylflavone-8-carboxylic acid
US3350411A (en) * 1963-10-10 1967-10-31 Pharma Seceph S A Soc D Expl C Process for preparing 3-methylflavone-8-carboxylic acid
BE757821A (fr) * 1970-08-01 1971-04-01 Recordati Chem Pharm Procede de preparation de l'acide 3-propionyl-salicylique et dederives de cet acide
GB1479518A (en) * 1973-12-27 1977-07-13 Erba Carlo Spa 5,6-benzo-ypsilon-pyrone derivatives
US4148900A (en) * 1973-12-27 1979-04-10 Carlo Erba S.P.A. 5:6-Benzo-γ-pyrone derivatives and process for their preparation
FR2281112A1 (fr) * 1974-08-05 1976-03-05 Lipha Nouveau medicament choleretique et anti-inflammatoire
GB1469823A (en) * 1974-08-13 1977-04-06 Farma Lepori Flavone derivatives
DE2549745A1 (de) * 1974-11-20 1976-05-26 Lipha Durch einen chromonylrest substituierte propionsaeuren sowie deren derivate und verwendungen

Also Published As

Publication number Publication date
YU43726B (en) 1989-10-31
IE54130B1 (en) 1989-06-21
SU1250171A3 (ru) 1986-08-07
JPH0214352B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-04-06
YU264982A (en) 1984-12-31
US4602034A (en) 1986-07-22
YU43675B (en) 1989-10-31
MA19650A1 (fr) 1983-07-01
US4783533A (en) 1988-11-08
NZ202596A (en) 1986-02-21
IE822752L (en) 1983-05-25
NO159169B (no) 1988-08-29
CA1213595A (fr) 1986-11-04
DK164163C (da) 1992-10-19
DK523082A (da) 1983-05-26
DK164163B (da) 1992-05-18
OA07257A (fr) 1984-04-30
ES517637A0 (es) 1983-08-16
ZA828436B (en) 1983-09-28
AU9073082A (en) 1983-06-02
MX173498B (es) 1994-03-10
EP0080934A1 (fr) 1983-06-08
CS248035B2 (en) 1987-01-15
EP0080934B1 (fr) 1988-01-13
YU163084A (en) 1985-03-20
HU192112B (en) 1987-05-28
IL67291A0 (en) 1983-03-31
DE3277970D1 (en) 1988-02-18
ES8308323A1 (es) 1983-08-16
NO159169C (no) 1988-12-07
DD204919A5 (de) 1983-12-14
JPS5896082A (ja) 1983-06-07
ATE31927T1 (de) 1988-01-15
AU563190B2 (en) 1987-07-02
IN158843B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-01-31
NO823940L (no) 1983-05-26
FR2516922A1 (fr) 1983-05-27

Similar Documents

Publication Publication Date Title
FR2516922B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB2128986B (en) Derivatives of 6 b-hydroxalkylpenicillanic acids as b-lactamase inhibitors
ZA817696B (en) N-substituted omega-(2-oxo-4-imidazolin-1-yl)alcanoic acids,salts and esters thereof,process for producing the same and these active agents containing pharmaceutical compounds
ES8406195A1 (es) Procedimiento para la obtencion de 1,2,3,4-tetrahidropiridinas
GR71716B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE3372364D1 (en) 1-carboxyalkanoylperhydroindole-2-carboxylic acids and derivatives
ATE117989T1 (de) Prostaglandinanaloge enthaltende lipidemulsion.
FR2319623A1 (fr) Procede de production d'un chrysanthemate d'alkyle optiquement actif
DK240184D0 (da) Beta-carboline-3-carboxylic acid derivatives and method of preparing the same
HU902612D0 (en) Process for the preparation of 4-phenylmethyl-1h-indole derivatives
IE811950L (en) Acrylic acid derivatives
FR2356658A1 (fr) Procede de production d'acides phosphinico-carboxyliques aliphatiques substitues
GB1302823A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE3167610D1 (en) Alpha-substituted ureidobenzylpenicillanic acid derivatives and process for producing the same
ATE27771T1 (de) Oxytetracyclin-loesungen.
JPS5283677A (en) Derivative of 2-(7-indenyloxymethyl)-4-substituted morpholine
DE2963352D1 (en) Therapeutic compositions containing as active compound a substituted acetic acid or its salt
TNSN89051A1 (fr) Composants substituants du flavonoide leurs sels leur manufacture et les medicaments contenant ces matieres
SU997401A1 (ru) Аммониевые соли замещенных фенилтиоуксусных кислот, обладающие противовоспалительной активностью
ES307804A1 (es) Procedimiento para la obtencion de esteres asimetricos del acido tiol o tionotiolfosforico

Legal Events

Date Code Title Description
ST Notification of lapse